For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of this treatment and Attruby represents a significant change. These groundbreaking therapies stabilize the transthyretin protein, halting its destructive build-up and lessening the b